SCHEMBL8348797

SCHEMBL8348797

Cc1ccc(-c2ccccc2)cc1NC(=O)C(N)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.48
SLC1A2 P43004 1/20 0.48
SLC1A1 P43005 1/20 0.48
HDAC1 Q13547 3/20 0.47
HDAC3 O15379 2/20 0.47
HDAC2 Q92769 2/20 0.47
BRD4 O60885 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 1/20 0.44
APOBEC3A P31941 1/20 0.44
GFER P55789 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 3/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
LMNA P02545 3/20 0.43
ALOX12 P18054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8347875 0.89 SLC1A3 (0.61) SLC1A3SLC1A2SLC1A1HDAC1HDAC3
SCHEMBL6717373 0.86 CASP2 (0.45) SLC1A3SLC1A2SLC1A1HDAC1HDAC3
SCHEMBL6718886 0.86 BRD4 (0.62) BRD4ALDH1A1KMT2AMEN1MAPT
SCHEMBL28609335 0.82 RAB9A (0.55) ALDH1A1MAPTNPC1RAB9ALMNA
SCHEMBL6718687 0.82 RAB9A (0.55) ALDH1A1MAPTNPC1RAB9ALMNA
SCHEMBL6718773 0.82 RAB9A (0.55) ALDH1A1MAPTNPC1RAB9ALMNA
SCHEMBL6717735 0.81 GAA (0.52) BRD4ALDH1A1KMT2AMEN1MAPT
SCHEMBL6717424 0.78 SLC1A3 (0.52) SLC1A3SLC1A2SLC1A1HDAC1HDAC3
Formic Acid SCHEMBL6717292 0.77 CYP1A2 (0.53) ALDH1A1KMT2AMAPTNPC1RAB9A
SCHEMBL6717088 0.77 MEN1 (0.56) BRD4ALDH1A1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022534-A1 ARYLGLYCINE DERIVATIVES FOR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed